ES2064564T3 - Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina. - Google Patents

Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.

Info

Publication number
ES2064564T3
ES2064564T3 ES90115881T ES90115881T ES2064564T3 ES 2064564 T3 ES2064564 T3 ES 2064564T3 ES 90115881 T ES90115881 T ES 90115881T ES 90115881 T ES90115881 T ES 90115881T ES 2064564 T3 ES2064564 T3 ES 2064564T3
Authority
ES
Spain
Prior art keywords
minocycline
unit dose
pressure release
release system
pulse pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90115881T
Other languages
English (en)
Inventor
Nitin Vadilal Sheth
Joseph James Valorose Jr
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Kieran George Mooney
Jerry Bain Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2064564T3 publication Critical patent/ES2064564T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

SISTEMA FARMACEUTICO CONTENIENDO 7 DIMETIL-6 DEOXY-6 DIMETILTETRACICLINA, COMPRENDIENDO UNA MEZCLA DE ACIDO NO TOXICO Y UNA ADICION DE SAL DEL MISMO, ADMINISTRADO SEPARADAMENTE UNA UNIDAD DE POLIMERO SENSITIVO AL PH. Y UNA ESPIRAL CIRCULAR GRANULADA, QUE LIBERA LA MINOCICLINA EN UN MEDIO TENIENDO UN PH. EN ALINEAMIENTO, DESDE APROXIMADAMENTE 4''0 A 7''5, LIBERANDO RAPIDAMENTE GRANULOS ADAPTADOS EN CUBIERTO O AL DESCUBIERTO, Y LIBERA MINOCICLINE EN UN MEDIO QUE TIENE UN PH. DE AL MENOS ALREDEDOR DE 3''9 DE MINOCLINA REDUCIDA A POLVO, UN PH. ADAPTADO Y OTROS COMPUESTOS, Y UNA DOSIS ORAL EN FORMA LIQUIDA, CAPSULAS O TABLETAS CONTENIENDO LO MISMO QUE LAS ANTERIORMENTE DICHAS. ESTOS SISTEMAS Y FORMULAS PROVEEN TERAPEUTICAMENTE A LA SANGRE DE MINOCICLINA AL MENOS DURANTE 24 H. CUANDO SE ADMINISTRAN UNA VEZ AL DIA. METODOS Y SISTEMAS PARA LA PREPARACION DE LAS FORMULAS PROVISTAS TAMBIEN.
ES90115881T 1989-09-21 1990-08-20 Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina. Expired - Lifetime ES2064564T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41070889A 1989-09-21 1989-09-21

Publications (1)

Publication Number Publication Date
ES2064564T3 true ES2064564T3 (es) 1995-02-01

Family

ID=23625892

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90115881T Expired - Lifetime ES2064564T3 (es) 1989-09-21 1990-08-20 Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.

Country Status (26)

Country Link
US (2) US5300304A (es)
EP (1) EP0418565B1 (es)
JP (1) JP3140764B2 (es)
KR (1) KR100187950B1 (es)
CN (1) CN1035039C (es)
AR (1) AR244547A1 (es)
AT (1) ATE114472T1 (es)
AU (1) AU624998B2 (es)
CA (1) CA2025703C (es)
CZ (1) CZ283048B6 (es)
DD (1) DD297558A5 (es)
DE (1) DE69014513T2 (es)
DK (1) DK0418565T3 (es)
ES (1) ES2064564T3 (es)
FI (1) FI96170C (es)
HK (1) HK1000315A1 (es)
HU (1) HU221804B1 (es)
IE (1) IE66389B1 (es)
IL (1) IL95423A (es)
NO (1) NO177038C (es)
NZ (1) NZ235319A (es)
PH (1) PH30777A (es)
PL (1) PL164770B1 (es)
PT (1) PT95353B (es)
SK (1) SK279358B6 (es)
ZA (1) ZA907546B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2064564T3 (es) * 1989-09-21 1995-02-01 American Cyanamid Co Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
TW212139B (es) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
AU742231B2 (en) * 1994-03-23 2001-12-20 Ortho-Mcneil Pharmaceutical, Inc. Multilayered controlled release pharmaceutical dosage form
IL109539A0 (en) * 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
AU4334700A (en) * 1999-04-06 2000-10-23 Shubha Chungi Pharmaceutical dosage form for pulsatile delivery of methylphenidate
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
EP1252887A4 (en) * 2000-01-27 2009-07-29 Mitsubishi Tanabe Pharma Corp EXTENDED RELEASE PREPARATION AND METHOD FOR MANUFACTURING THE SAME
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6730320B2 (en) * 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
IT1318625B1 (it) 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
CA2447008A1 (en) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
ES2534827T3 (es) 2003-04-07 2015-04-29 Supernus Pharmaceuticals, Inc. Formulaciones de tetraciclinas en dosis única diaria
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653932A1 (en) * 2003-07-24 2006-05-10 Ranbaxy Laboratories Limited Modified release compositions for minocycline
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
CN1332937C (zh) * 2003-12-31 2007-08-22 赤峰东陵药业有限责任公司 新四环霉素类衍生物
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US20060078621A1 (en) * 2004-10-13 2006-04-13 Wedinger Robert S Method of providing customized drug delivery systems
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20100215744A1 (en) * 2008-08-06 2010-08-26 Medicis Pharmaceutical Corporation Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
MX2008002512A (es) * 2005-08-26 2008-04-03 Bpsi Holdings Inc Composiciones de farmaco que contienen matrices de hipromelosa con liberacion controlada.
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
CA2639406A1 (en) * 2006-01-24 2007-08-02 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CN100512689C (zh) * 2006-09-28 2009-07-15 江南大学 一种用于降低卷烟烟气中焦油及自由基的添加剂及其添加方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2010017310A1 (en) * 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
EP3220899A1 (en) 2014-11-19 2017-09-27 Nestlé Skin Health SA Modified release doxycycline composition
US11103517B2 (en) * 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
SG11201807999XA (en) * 2016-03-29 2018-10-30 Ptt Global Chemical Public Co Ltd Coalescing agent derived from succinate ester
GB2551980A (en) * 2016-06-30 2018-01-10 Commw Scient Ind Res Org Method and system for low level metal analysis of mineral samples

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB310814A (en) * 1927-08-05 1929-05-31 Bates Valve Bag Corp Method of and apparatus for filling bags
GB327295A (en) * 1929-04-12 1930-04-03 Edward Lloyd Pease Improvements in or relating to tanks having external cooling elements, applicable tooil tanks for electrical transformers
NL270408A (es) * 1960-10-20
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3356571A (en) * 1964-11-25 1967-12-05 American Cyanamid Co Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ES2064564T3 (es) * 1989-09-21 1995-02-01 American Cyanamid Co Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.

Also Published As

Publication number Publication date
EP0418565A2 (en) 1991-03-27
US5300304A (en) 1994-04-05
NO177038B (no) 1995-04-03
EP0418565A3 (en) 1991-09-25
NO177038C (no) 1995-07-12
PH30777A (en) 1997-10-17
PL164770B1 (pl) 1994-10-31
IE66389B1 (en) 1995-12-27
ZA907546B (en) 1991-07-31
KR100187950B1 (ko) 1999-06-01
CZ283048B6 (cs) 1997-12-17
DE69014513T2 (de) 1995-05-24
FI96170C (fi) 1996-05-27
US5413777A (en) 1995-05-09
CN1050320A (zh) 1991-04-03
HU906006D0 (en) 1991-03-28
DD297558A5 (de) 1992-01-16
JPH03112930A (ja) 1991-05-14
NZ235319A (en) 1993-03-26
HK1000315A1 (en) 1998-02-27
EP0418565B1 (en) 1994-11-30
FI96170B (fi) 1996-02-15
NO904099D0 (no) 1990-09-20
FI904634A0 (fi) 1990-09-20
CN1035039C (zh) 1997-06-04
AR244547A1 (es) 1993-11-30
AU624998B2 (en) 1992-06-25
DK0418565T3 (da) 1995-01-23
HU221804B1 (hu) 2003-01-28
IE903398A1 (en) 1991-04-10
DE69014513D1 (de) 1995-01-12
ATE114472T1 (de) 1994-12-15
AU6303190A (en) 1991-03-28
SK455990A3 (en) 1998-10-07
HUT59314A (en) 1992-05-28
CA2025703A1 (en) 1991-03-22
CZ455990A3 (en) 1997-08-13
SK279358B6 (sk) 1998-10-07
NO904099L (no) 1991-03-22
JP3140764B2 (ja) 2001-03-05
PT95353A (pt) 1991-08-14
IL95423A0 (en) 1991-06-30
IL95423A (en) 1994-11-11
KR910005875A (ko) 1991-04-27
PT95353B (pt) 1998-05-29
CA2025703C (en) 2002-08-27
PL286971A1 (en) 1992-01-27

Similar Documents

Publication Publication Date Title
ES2064564T3 (es) Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
MY102459A (en) Oral sustained release pharmaceutical preparation.
AR065827A2 (es) Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina, composicion farmaceutica, procedimiento y preparacion y su uso en terapia
DE69325402D1 (de) Verbessertes System des Typs einmal täglich zur gepulsten Minocyclinabgabe
TNSN97055A1 (fr) Derives de 6-phenylpyridyl -2- amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69212882T2 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
ATE43497T1 (de) Pharmazeutische formulierung mit gesteuerter absorption.
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
IT8220758A1 (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
DE69427981T2 (de) Verkapselter arzneistoff
NO991613L (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
DE59305805D1 (de) Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
GB1357737A (en) Sustained release pharmaceutical compositions
AR004196A1 (es) Un metodo a alta velocidad para preparar granulos esfericos que comprende un medicamento para uso farmaceutico, granulos obtenibles mediante este metodoy una bolsita que contiene dichos granulos
ATE78168T1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
NO164958C (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
GB1219026A (en) Tablet preparation
GEP20053457B (en) Low Hygroscopic Aripiprazole Drug Substance and Processes for Preparation Thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 418565

Country of ref document: ES